A Lowy

1.8k total citations
37 papers, 1.1k citations indexed

About

A Lowy is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Epidemiology. According to data from OpenAlex, A Lowy has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in A Lowy's work include T-cell and B-cell Immunology (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). A Lowy is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). A Lowy collaborates with scholars based in Switzerland, United States and United Kingdom. A Lowy's co-authors include Donald J. Chisholm, Stuart M. Furler, Ann M. Poynten, Gregory J. Cooney, Bronwyn A. Ellis, Edward W. Kraegen, M I Greene, Richard D. Granstein, Kamlesh Khunti and Richard Baker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

A Lowy

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Lowy Switzerland 18 296 246 214 162 132 37 1.1k
Kiyoko Yagyu Japan 24 184 0.6× 428 1.7× 148 0.7× 212 1.3× 349 2.6× 46 1.4k
Edward Ruiz-Narváez United States 26 233 0.8× 347 1.4× 151 0.7× 174 1.1× 210 1.6× 91 1.7k
Elisabetta Zanolin Italy 16 290 1.0× 226 0.9× 114 0.5× 252 1.6× 92 0.7× 40 1.7k
André Ulmann France 22 147 0.5× 131 0.5× 488 2.3× 113 0.7× 41 0.3× 49 2.5k
Fang Ma China 19 238 0.8× 313 1.3× 193 0.9× 126 0.8× 75 0.6× 65 1.2k
Lisa Nelson United States 18 254 0.9× 173 0.7× 57 0.3× 77 0.5× 192 1.5× 29 1.2k
Deborah L. Jones United States 17 336 1.1× 416 1.7× 101 0.5× 296 1.8× 38 0.3× 38 1.5k
Maziar Rahmani Canada 20 182 0.6× 352 1.4× 158 0.7× 271 1.7× 100 0.8× 42 2.0k
Norma C. Serrano Colombia 21 156 0.5× 141 0.6× 212 1.0× 249 1.5× 43 0.3× 72 1.4k
Robert L. Thomas United States 11 158 0.5× 603 2.5× 64 0.3× 446 2.8× 92 0.7× 31 1.4k

Countries citing papers authored by A Lowy

Since Specialization
Citations

This map shows the geographic impact of A Lowy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Lowy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Lowy more than expected).

Fields of papers citing papers by A Lowy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Lowy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Lowy. The network helps show where A Lowy may publish in the future.

Co-authorship network of co-authors of A Lowy

This figure shows the co-authorship network connecting the top 25 collaborators of A Lowy. A scholar is included among the top collaborators of A Lowy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Lowy. A Lowy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capkun-Niggli, Gorana, Raquel Lahoz, E. Verdun, et al.. (2013). Medical and Pharmacy Claims-Based Algorithms for Identifying Relapses in Patients with Multiple Sclerosis. Value in Health. 16(7). A582–A582. 4 indexed citations
3.
Burnier, Michel, et al.. (2011). Impact of prolonged antihypertensive duration of action on predicted clinical outcomes in imperfectly adherent patients: comparison of aliskiren, irbesartan and ramipril. International Journal of Clinical Practice. 65(2). 127–133. 17 indexed citations
4.
Lowy, A, Veronica C. Munk, Michel Burnier, et al.. (2010). Effects on blood pressure and cardiovascular risk of variations in patients’ adherence to prescribed antihypertensive drugs: role of duration of drug action. International Journal of Clinical Practice. 65(1). 41–53. 31 indexed citations
5.
Nixon, Richard M., Eugenio E. Müller, A Lowy, & Heather Falvey. (2009). Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach. International Journal of Clinical Practice. 63(5). 766–775. 57 indexed citations
6.
George, S., Peter Pockney, John Primrose, et al.. (2008). A prospective randomised comparison of minor surgery in primary and secondary care. The MiSTIC trial. Health Technology Assessment. 12(23). iii–iv, ix. 38 indexed citations
7.
Lowy, A, et al.. (2005). Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men. Diabetes Obesity and Metabolism. 7(3). 273–281. 9 indexed citations
8.
Boulay, Jean‐Louis, Gabriele Mild, A Lowy, et al.. (2002). SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. British Journal of Cancer. 87(6). 630–634. 61 indexed citations
9.
Bernhard, J., A Lowy, Rudolf Maibach, & Christoph Hürny. (2001). Response shift in the perception of health for utility evaluation. European Journal of Cancer. 37(14). 1729–1735. 36 indexed citations
10.
Khunti, Kamlesh, et al.. (2001). Inequalities in provision of systematic care for patients with diabetes. Family Practice. 18(1). 27–32. 23 indexed citations
11.
Furler, Stuart M., Ann M. Poynten, Adamandia D. Kriketos, et al.. (2001). Independent Influences of Central Fat and Skeletal Muscle Lipids on Insulin Sensitivity. Obesity Research. 9(9). 535–543. 43 indexed citations
12.
Lapsys, Naras M., Adamandia D. Kriketos, Ann M. Poynten, et al.. (2000). Expression of Genes Involved in Lipid Metabolism Correlate with Peroxisome Proliferator-Activated Receptor γ Expression in Human Skeletal Muscle1. The Journal of Clinical Endocrinology & Metabolism. 85(11). 4293–4297. 79 indexed citations
13.
Thomas, Kate, et al.. (1993). Case against targeting long term non-attenders in general practice for a health check.. PubMed. 43(372). 285–9. 8 indexed citations
14.
Urbain, Jacques, A Lowy, John G. Monroe, et al.. (1986). Anti-idiotypic treatment of BALB/c mice induces CRIa-bearing suppressor cells with altered Igh-restricted function.. The Journal of Immunology. 136(6). 1968–1973. 3 indexed citations
15.
Lowy, A, et al.. (1985). Subluxing peroneal tendons. Treatment with the use of an autogenous sliding bone graft. Journal of the American Podiatric Medical Association. 75(5). 249–253. 6 indexed citations
16.
Monroe, John G., et al.. (1985). Genetic and biological characterization of a T suppressor cell induced by anti-idiotypic antibody.. The Journal of Immunology. 135(3). 1589–1597. 10 indexed citations
17.
Sy, Man‐Sun, A Lowy, Kent T. HayGlass, et al.. (1984). Chronic treatment with rabbit anti-mouse mu-chain antibody alters the characteristic immunoglobulin heavy-chain restriction of murine suppressor T-cell factors.. Proceedings of the National Academy of Sciences. 81(12). 3846–3850. 53 indexed citations
18.
Flood, Patrick M., et al.. (1983). Igh variable region-restricted T cell interactions. Genetic restriction of an antigen-specific suppressor inducer factor is imparted by an I-J+ antigen-nonspecific molecule.. The Journal of Experimental Medicine. 158(6). 1938–1947. 15 indexed citations
19.
Lowy, A, A Tominaga, Jeffrey A. Drebin, et al.. (1983). Identification of an I-J+ antigen-presenting cell required for third order suppressor cell activation.. The Journal of Experimental Medicine. 157(1). 353–358. 46 indexed citations
20.
Takaoki, Muneo, Man‐Sun Sy, A Tominaga, et al.. (1982). I-J-restricted interactions in the generation of azobenzenearsonate-specific suppressor T cells.. The Journal of Experimental Medicine. 156(5). 1325–1334. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026